CMRX Chimerix Inc

Price (delayed)

$7.92

Market cap

$496.06M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.5

Enterprise value

$460.85M

Sector: Healthcare
Industry: Biotechnology

Highlights

The EPS has soared by 78% YoY and by 68% from the previous quarter
The net income has soared by 71% YoY and by 64% from the previous quarter
CMRX's quick ratio has soared by 55% year-on-year but it is down by 23% since the previous quarter
The company's gross profit rose by 3.8% YoY but it fell by 3.1% QoQ
The debt has grown by 27% from the previous quarter
The equity has declined by 26% year-on-year and by 11% since the previous quarter

Key stats

What are the main financial stats of CMRX
Market
Shares outstanding
62.63M
Market cap
$496.06M
Enterprise value
$460.85M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
5.92
Price to sales (P/S)
44.74
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
41.82
Earnings
Revenue
$11.02M
EBIT
-$35.35M
EBITDA
-$34.99M
Free cash flow
-$30.52M
Per share
EPS
-$0.5
Free cash flow per share
-$0.49
Book value per share
$1.34
Revenue per share
$0.18
TBVPS
$1.5
Balance sheet
Total assets
$93.5M
Total liabilities
$10.34M
Debt
$2.92M
Equity
$83.17M
Working capital
$82.83M
Liquidity
Debt to equity
0.04
Current ratio
12.18
Quick ratio
11.89
Net debt/EBITDA
1.01
Margins
EBITDA margin
-317.6%
Gross margin
100%
Net margin
-320.8%
Operating margin
-332.4%
Efficiency
Return on assets
-33.5%
Return on equity
-36.5%
Return on invested capital
-53.3%
Return on capital employed
-41.1%
Return on sales
-320.8%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

CMRX stock price

How has the Chimerix stock price performed over time
Intraday
-2.22%
1 week
-5.94%
1 month
51.15%
1 year
288.24%
YTD
63.98%
QTD
63.98%

Financial performance

How have Chimerix's revenue and profit performed over time
Revenue
$11.02M
Gross profit
$11.02M
Operating income
-$36.63M
Net income
-$35.35M
Gross margin
100%
Net margin
-320.8%
The net margin has soared by 73% YoY and by 63% from the previous quarter
The company's operating margin has surged by 72% YoY and by 62% QoQ
The net income has soared by 71% YoY and by 64% from the previous quarter
The operating income has soared by 71% YoY and by 63% QoQ

Growth

What is Chimerix's growth rate over time

Valuation

What is Chimerix stock price valuation
P/E
N/A
P/B
5.92
P/S
44.74
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
41.82
The EPS has soared by 78% YoY and by 68% from the previous quarter
The equity has declined by 26% year-on-year and by 11% since the previous quarter
CMRX's P/S is 42% higher than its 5-year quarterly average of 31.5
Chimerix's revenue has increased by 3.8% YoY but it has decreased by 3.1% from the previous quarter

Efficiency

How efficient is Chimerix business performance
The ROS has soared by 73% YoY and by 63% from the previous quarter
Chimerix's return on equity has surged by 61% QoQ and by 56% YoY
CMRX's return on assets has surged by 61% since the previous quarter and by 55% year-on-year
Chimerix's ROIC has soared by 58% from the previous quarter and by 50% YoY

Dividends

What is CMRX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for CMRX.

Financial health

How did Chimerix financials performed over time
CMRX's quick ratio has soared by 55% year-on-year but it is down by 23% since the previous quarter
The current ratio has grown by 49% year-on-year but it has declined by 23% since the previous quarter
The debt is 96% less than the equity
The equity has declined by 26% year-on-year and by 11% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.